entertainment -WSS

entertainment

author：entertainment 2025-10-01 22:16:39 - browse：43

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Take antibiotics after sex, CDC recommends for certain risk groups

WSS

Judge denies Trump's request for new trial in E. Jean Carroll case

In rare move, senator releases unverified FBI source report alleging Biden bribe

Data don't support strong claims for Covid

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

ASCO Daily Recap: CAR

Senators tussle over abortion against the backdrop of a presidential campaign

focus

entertainment

explore

Trump demands the U.S. pay no more for drugs than other countries … again

The stock market has soared this year, but will it last? Experts weigh in

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Medical leaders decry Supreme Court decision on affirmative action

Are infertility treatments 'essential' during the Covid

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage's lean provider networks lead CMS complaints

The high cost of giving birth even with insurance

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

leisure time

Finland to offer bird flu vaccine to select groups of people, a possible global first

For pregnant people, addiction treatment shouldn't mean a call to child protective services

An outdated Medicare rule harms dementia patients with anxiety

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

focus

focus

hotspot

leisure time